TNFSF10 and Alzheimer disease: Fisher post-hoc tests confirmed that inflammatory mediator levels were significantly suppressed in the late stages (IL-1β, IL-18, TRAIL, MIP-1) or both the intermediate and late stages (IL-6, LIF-1, GM-CSF, IP-10) of AD (Figures 5 and 6).